---
figid: PMC9649345__gr1
pmcid: PMC9649345
image_filename: gr1.jpg
figure_link: /pmc/articles/PMC9649345/figure/f0005/
number: Fig. 1
figure_title: ''
caption: C57BL/6 mice were treated with 1% DNCB in acetone/olive oil (3:1) on days
  −4 and 0. Then, mice were challenged with 1% DNCB thrice weekly for three Then,
  mice were challenged with 1% DNCB thrice weekly for three weeks (days 1–21). AD-like
  lesions were treated with AYZ (6.24 g/kg) or SDQP (0.96 g/kg) or CHT (1.3 mg/kg)
  for three weeks.
article_title: Angelica Yinzi alleviates 1-chloro-2,4-dinitrobenzene-induced atopic
  dermatitis by inhibiting activation of NLRP3 inflammasome and down-regulating the
  MAPKs/NF-kB signaling pathway.
citation: Wei Liu, et al. Saudi Pharm J. 2022 Oct;30(10):1426-1434.
year: '2022'

doi: 10.1016/j.jsps.2022.07.003
journal_title: 'Saudi Pharmaceutical Journal : SPJ'
journal_nlm_ta: Saudi Pharm J
publisher_name: Elsevier

keywords:
- Angelica Yinzi
- Atopic dermatitis
- MAPK
- NLRP3
- Inflammation

---
